Cargando…
Effects of clazosentan, cilostazol, and statins on aneurysmal subarachnoid hemorrhage: A protocol for systematic review and meta-analysis
BACKGROUND: : Aneurysmal subarachnoid hemorrhage (aSAH) is a disease caused by the infiltration of blood into the subarachnoid space due to the rupture of an intracranial aneurysm. It is a serious cerebrovascular disease, with a mortality rate of about 40% worldwide, which seriously threatens human...
Autores principales: | He, Junfang, Zhang, Li, Yu, Yao, Luo, Xinyue, Wei, Min, Chen, Gen, Shen, Yanfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440251/ https://www.ncbi.nlm.nih.gov/pubmed/32332668 http://dx.doi.org/10.1097/MD.0000000000019902 |
Ejemplares similares
-
Effect of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Xiang, et al.
Publicado: (2012) -
Septic cavernous sinus thrombosis presenting as acute cerebral infarction and aneurysmal subarachnoid hemorrhage: Case report
por: He, Pengchen, et al.
Publicado: (2023) -
Injury of optic radiation and visual field defect in a patient with aneurysmal subarachnoid hemorrhage: A case report
por: Jang, Sung Ho, et al.
Publicado: (2017) -
Associations of neutrophil to lymphocyte ratio and red cell distribution width on different days with the prognosis of aneurysmal subarachnoid hemorrhage patients
por: Min, Jie, et al.
Publicado: (2023) -
Subarachnoid hemorrhage and COVID-19: Association or coincidence?
por: Cezar-Junior, Auricelio Batista, et al.
Publicado: (2020)